Cargando…
Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases
Systemic inflammatory rheumatic diseases are considered as autoimmune diseases, meaning that the balance between recognition of pathogens and avoidance of self-attack is impaired and the immune system attacks and destroys its own healthy tissue. Treatment with conventional Disease Modifying Antirheu...
Autores principales: | Ciechomska, Marzena, O'Reilly, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995328/ https://www.ncbi.nlm.nih.gov/pubmed/27594771 http://dx.doi.org/10.1155/2016/9607946 |
Ejemplares similares
-
Interleukin-6: a new therapeutic target in systemic sclerosis?
por: O'Reilly, Steven, et al.
Publicado: (2013) -
IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics
por: O’Reilly, Steven, et al.
Publicado: (2016) -
Corrigendum: IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics
por: O’Reilly, Steven, et al.
Publicado: (2016) -
Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
por: Felis-Giemza, Anna, et al.
Publicado: (2023) -
Designing Studies for Epigenetic Biomarker Development in Autoimmune Rheumatic Diseases
por: de la Calle-Fabregat, Carlos, et al.
Publicado: (2022)